The Company is seeking a Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances to lead the strategic and integrated planning of its oncology portfolio. The successful candidate will be responsible for owning the 3-year strategic MEG plan for oncology, setting direction and priorities across the full portfolio of studies, and ensuring alignment with unmet medical needs and enterprise business priorities. This role requires a leader with an advanced scientific degree and at least 15 years of experience, including a minimum of 5 years in clinical trial expertise. The VP will also be accountable for the governance of the oncology MEG book of work, driving innovation in evidence generation approaches, and championing a data-driven strategy. Applicants for this role at the company should have a formal specialization in areas associated with the current oncology portfolio, with a preference for those with professional experience in solid tumor and/or hematology. The role demands a leader with a proven track record in cross-functional alignment, influence, and outcome-driven execution. The VP will be expected to lead a large team, build organizational talent, and engage with external stakeholders as a trusted senior expert. An entrepreneurial mindset, strong executive presence, and the ability to influence effectively across senior cross-functional teams are essential. The position is HQ-based with an international and domestic travel requirement of approximately 25%.

Hiring Company

Bristol-Myers Squibb